Statin use in older people primary prevention on cardiovascular disease: an updated systematic review and meta-analysis

被引:0
|
作者
Huang, Hao [1 ]
Zhu, Hechen [2 ]
Ya, Ru [1 ]
机构
[1] Shanghai Third Rehabil Hosp, Dept Crit Rehabil, Shanghai 200436, Peoples R China
[2] Fudan Univ, Huashan Hosp, Dept Crit Care Med, Shanghai 200031, Peoples R China
关键词
statin; older people; cardiovascular disease; primary prevention; meta; -analysis; CORONARY-HEART-DISEASE; CHOLESTEROL LEVELS; GLOBAL BURDEN; ALL-CAUSE; ASSOCIATION; EVENTS; RISK; GUIDELINES; MORTALITY; ADULTS;
D O I
10.31083/j.rcm2304114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Evidence on statin use for primary prevention of cardiovascular disease (CVD) in older people needs to be extended and updated, aiming to provide further guidance for clinical practice. Methods: PubMed, EMBASE, Cochrane Library and Web of Science were searched for eligible observational studies comparing statin use vs. no-statin use for primary prevention of CVD in older people (age 20% diabetic populations (HR: 0.50, 95% CI: 0.40-0.64), and 50% hypertensive populations (HR: 0.38, 95% CI: 0.16-0.88). Conclusions: Statin use was related to a 46%, 49%, 17%, 21% and 25% risk reduction on all-cause mortality, CVD mortality, CHD/MI, stroke and total CV events in older patients, respectively. The significant association was also addressed in older patients and 75 years old individuals for CVD primary prevention.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk
    Ashish Sarraju
    Gabriela Spencer-Bonilla
    Sukyung Chung
    Sofia Gomez
    Jiang Li
    Paul Heidenreich
    Latha Palaniappan
    Fatima Rodriguez
    Journal of General Internal Medicine, 2022, 37 : 2642 - 2649
  • [42] Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis
    Zhang, Jufen
    Dierckx, Riet
    Mohee, Kevin
    Clark, Andrew L.
    Cleland, John G.
    ESC HEART FAILURE, 2017, 4 (01): : 40 - 45
  • [43] USE OF COLCHICINE FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Kassab, Kameel
    Chuy, Katherine Lee
    Vij, Aviral
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 24 - 24
  • [44] Aspirin Use for Primary Prevention of Cardiovascular Disease in Older Patients: A Review of Clinical Guidelines and Updated Evidence
    Lewis, Jelena
    Bethishou, Laressa
    Tsu, Laura, V
    SENIOR CARE PHARMACIST, 2019, 34 (09): : 580 - 594
  • [45] Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis
    Warshafsky, Stephen
    Lee, David H.
    Francois, Louise K.
    Nowakowski, John
    Nadelman, Robert B.
    Wormser, Gary P.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1137 - 1144
  • [46] The risk of Parkinson's disease in diabetic people: an updated systematic review and meta-analysis
    Azami, Mobin
    Moradkhani, Asra
    Afraie, Maryam
    Khateri, Sorour
    Sharifian, Erfan
    Zamani, Kamran
    Moradi, Yousef
    ACTA NEUROLOGICA BELGICA, 2024, 124 (03) : 775 - 790
  • [47] Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular Disease
    Micha, Renata
    Imamura, Fumiaki
    von Ballmoos, Moritz Wyler
    Solomon, Daniel H.
    Hernan, Miguel A.
    Ridker, Paul M.
    Mozaffarian, Dariush
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (09): : 1362 - 1370
  • [48] Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis
    Ioannis Bellos
    Smaragdi Marinaki
    Pagona Lagiou
    Vassiliki Benetou
    American Journal of Cardiovascular Drugs, 2024, 24 : 241 - 253
  • [49] Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis
    Bontempo, S.
    Yeganeh, L.
    Giri, R.
    Vincent, A. J.
    CLIMACTERIC, 2024, 27 (01) : 93 - 103
  • [50] Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis
    Bellos, Ioannis
    Marinaki, Smaragdi
    Lagiou, Pagona
    Benetou, Vassiliki
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024, 24 (02) : 241 - 253